These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31686902)

  • 41. Impact of Disease on Amikacin Pharmacokinetics and Dosing in Children.
    Liu X; Smits A; Wang Y; Renard M; Wead S; Kagan RJ; Healy DP; De Cock P; Allegaert K; Sherwin CMT
    Ther Drug Monit; 2019 Feb; 41(1):44-52. PubMed ID: 30299427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency.
    Eichenbaum G; Göhler K; Etropolski M; Steigerwald I; Pergolizzi J; Kim M; Vorsanger G
    J Opioid Manag; 2015; 11(3):211-27. PubMed ID: 25985806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population pharmacokinetics of riociguat in a pediatric population (aged ≥ 6 years) with pulmonary arterial hypertension.
    Willmann S; Keller AK; Meyer M; van der Mey D; Wirsching G; Zhang Y; Drenth HJ; Keunecke A; Vendel E; Saleh S
    Pediatr Pulmonol; 2023 Mar; 58(3):908-917. PubMed ID: 36507572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity.
    Leone C; Di Stefano G; Di Pietro G; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Finnerup NB; Garcia-Larrea L; Li T; Goetz M; Mouraux A; Pelz B; Pogatzki-Zahn E; Schilder A; Schnetter E; Schubart K; Tracey I; Troconiz IF; Van Niel H; Hernandez JMV; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Phillips KG; Truini A; Treede RD
    Trials; 2022 Sep; 23(1):739. PubMed ID: 36064434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain.
    Vorsanger G; Xiang J; Okamoto A; Upmalis D; Moskovitz B
    J Opioid Manag; 2010; 6(3):169-79. PubMed ID: 20642246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain.
    Daniels SE; Upmalis D; Okamoto A; Lange C; Häeussler J
    Curr Med Res Opin; 2009 Mar; 25(3):765-76. PubMed ID: 19203298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tapentadol immediate release: a new treatment option for acute pain management.
    Afilalo M; Stegmann JU; Upmalis D
    J Pain Res; 2010 Feb; 3():1-9. PubMed ID: 21197304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation.
    Wang H; Jones AK; Dvorak CC; Huang L; Orchard P; Ivaturi V; Long-Boyle J
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1603-1610. PubMed ID: 31002993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis.
    Denti P; Garcia-Prats AJ; Draper HR; Wiesner L; Winckler J; Thee S; Dooley KE; Savic RM; McIlleron HM; Schaaf HS; Hesseling AC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.
    Albers S; Meibohm B; Mir TS; Läer S
    Br J Clin Pharmacol; 2008 Apr; 65(4):511-22. PubMed ID: 17995971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tapentadol hydrochloride: a centrally acting oral analgesic.
    Wade WE; Spruill WJ
    Clin Ther; 2009 Dec; 31(12):2804-18. PubMed ID: 20110020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling and simulation approaches to evaluate pharmacokinetic sampling contamination from central venous catheters in pediatric pharmacokinetic studies of actinomycin-D: a report from the children's oncology group.
    Edwards AY; Skolnik JM; Dombrowsky E; Patel D; Barrett JS
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):83-94. PubMed ID: 22623208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation.
    Damian MA; Hammer GB; Elkomy MH; Frymoyer A; Drover DR; Su F
    Anesth Analg; 2020 Jan; 130(1):209-216. PubMed ID: 30198929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population pharmacokinetics of oral risperidone in children, adolescents and adults with psychiatric disorders.
    Thyssen A; Vermeulen A; Fuseau E; Fabre MA; Mannaert E
    Clin Pharmacokinet; 2010 Jul; 49(7):465-78. PubMed ID: 20528007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Effectiveness and Tolerability of Pain Treatment with Tapentadol Prolonged Release.
    Mateos RG; Bernal DS; Morera LMT; Ferri CM; Escobar AE
    Pain Physician; 2021 Jan; 24(1):E75-E85. PubMed ID: 33400440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia.
    Cheng X; Zhao Y; Gu H; Zhao L; Zang Y; Wang X; Wu R
    Int J Immunopathol Pharmacol; 2020; 34():2058738420934936. PubMed ID: 32720540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population Pharmacokinetics and Exposure-Safety Relationships of Alisertib in Children and Adolescents With Advanced Malignancies.
    Zhou X; Mould DR; Yuan Y; Fox E; Greengard E; Faller DV; Venkatakrishnan K
    J Clin Pharmacol; 2022 Feb; 62(2):206-219. PubMed ID: 34435684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial.
    Buynak R; Rappaport SA; Rod K; Arsenault P; Heisig F; Rauschkolb C; Etropolski M
    Clin Ther; 2015 Nov; 37(11):2420-38. PubMed ID: 26428249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.